Amylyx Pharmaceuticals Inc (AMLX) — Financial Flexibility Index
Amylyx Pharmaceuticals Inc (AMLX) has a Financial Flexibility Index of -1.80x as of March 2026. Free cash flow of $-36.88 Million (operating CF $-36.88 Million minus capex $0.00) represents -2% of total liabilities ($20.44 Million). Also explore Amylyx Pharmaceuticals Inc (AMLX) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Amylyx Pharmaceuticals Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Amylyx Pharmaceuticals Inc across 7 annual periods. Check Amylyx Pharmaceuticals Inc (AMLX) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Amylyx Pharmaceuticals Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Amylyx Pharmaceuticals Inc. For the full company profile including market capitalisation, see AMLX stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.50x | $-123.20 Million | $-123.34 Million | $27.39 Million | ▲ +22.5% |
| 2024 | -5.80x | $-167.49 Million | $-167.65 Million | $28.87 Million | ▼ -3804.2% |
| 2023 | 0.16x | $13.16 Million | $11.92 Million | $84.02 Million | ▲ +104.5% |
| 2022 | -3.49x | $-177.34 Million | $-179.87 Million | $50.85 Million | ▼ -1103.1% |
| 2021 | -0.29x | $-74.45 Million | $-74.80 Million | $256.78 Million | ▲ +35.9% |
| 2020 | -0.45x | $-36.55 Million | $-36.70 Million | $80.83 Million | ▼ -22.6% |
| 2019 | -0.37x | $-10.54 Million | $-10.69 Million | $28.58 Million | — |